共 29 条
[1]
Lipsky B(1990)Outpatient management of uncomplicated lower-extremity infections in diabetic patients Arch Intern Med 150 790-797
[2]
Pecoraro R(2003)Infections in diabetic foot ulcerations Curr Infect Dis Rep 5 391-397
[3]
Larson S(1994)Use of ampicillin/ sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients Clin Infect Dis 18 683-693
[4]
Joseph WS(2003)National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2003, issued August 2003 Am J Infect Control 31 481-498
[5]
Tan JS(1999)Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus--Minnesota and North Dakota, 1997–1999 MMWR Morb Mortal Wkly Rep 48 707-710
[6]
Grayson M(2003)Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection JAMA 290 2976-2984
[7]
Gibbons G(2004)Glycopeptide antibiotics: from conventional molecules to new derivatives Drugs 64 913-936
[8]
Habershaw G(2004)The glycylcyclines. A comparative review with the tetracyclines Drugs 64 63-88
[9]
Naimi TS(1997)Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility J Antimicrob Chemother 40 135-136
[10]
LeDell KH(2003)Epidemiology and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997–2001 Clin Infect Dis 36 429-439